SCHEMBL5712969

SCHEMBL5712969

O=C(O)CN1C(=O)[C@@H](NC(=O)c2nccc3ccccc23)COc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.55
ACE P12821 3/20 0.55
RIPK1 Q13546 11/20 0.49
XIAP P98170 2/20 0.47
CASP1 P29466 3/20 0.45
CASP8 Q14790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5713036 0.88 MME (0.49) MMEACERIPK1XIAPCASP1
SCHEMBL5712978 0.82 CASP1 (0.46) CASP1CASP8
SCHEMBL8521265 0.82 CASP1 (0.46) CASP1CASP8
SCHEMBL5712985 0.78 CASP1 (0.48) RIPK1XIAPCASP1
SCHEMBL10710600 0.73 ACE (0.66) MMEACERIPK1XIAP
SCHEMBL10710592 0.73 ACE (0.66) MMEACERIPK1XIAP
SCHEMBL7876213 0.73 ACE (0.61) MMEACERIPK1XIAP
SCHEMBL7876214 0.73 ACE (0.61) MMEACERIPK1XIAP
SCHEMBL30494489 0.73 ACE (0.61) MMEACERIPK1XIAP
SCHEMBL8520881 0.71 CASP1 (0.46) CASP1CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942925-B1 INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME VERTEX PHARMA (US) 2006-11-22 EP disclosed
EP-1466921-A1 Inhibitors of interleukin-1 beta converting enzyme Vertex Pharmaceuticals Incorporated (US) 2004-10-13 EP disclosed
US-6350741-B1 1-BENZAZEPINE DERIVATIVES; ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS; BONE AND AUTOIMMUNE DISORDER TREATMENT VERTEX PHARMACEUTICAL, INC. 2002-02-26 US disclosed